Reuven B. Young

We advised the underwriters on the SEC-registered offering

We advised Oncopeptides on the private placement of shares

We advised the dealer managers on the debt tender offers

We advised the joint bookrunners on the transaction

We advised the initial purchasers on the Rule 144A / Regulation S offering

Davis Polk advised NKT A/S in connection with its rights offering relating to 10,744,009 new shares. The offering consisted of a public offering in Denmark and a private placement to…

Davis Polk is advising the joint-bookrunners to Electrocomponents plc on its placing of 21,518,181 million new ordinary shares at 825 pence per share. Concurrently with the placing, retail…

Davis Polk advised the dealer managers in connection with cash tender offers by Commonwealth Bank of Australia to purchase certain of its outstanding debt securities. Headquartered in…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Prosus N.V. of $1.5 billion principal amount of 3.832% notes due 2051 under its $6 billion…

Davis Polk advised the joint book-running managers in connection with a Rule 144A / Regulation S offering of $500 million aggregate principal amount of 1.729% senior notes due 2030 by…